pyrroles has been researched along with cym-5520 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhhatarai, B; Brown, SJ; Cayanan, C; Eberhart, C; Guerrero, M; Hodder, P; Roberts, E; Rosen, H; Saldana, A; Satsu, H; Schaeffer, MT; Schürer, S | 1 |
| Burkhart, C; Haberhauer, G; Heusch, G; Keul, P; Levkau, B; Manthe, K; Vaidya, M; von Wnuck Lipinski, K; Weske, S | 1 |
2 other study(ies) available for pyrroles and cym-5520
| Article | Year |
|---|---|
A sphingosine 1-phosphate receptor 2 selective allosteric agonist.
Topics: Allosteric Regulation; Animals; Binding Sites; CHO Cells; Cricetinae; Cricetulus; High-Throughput Screening Assays; Humans; Kinetics; Ligands; Molecular Docking Simulation; Mutation; Protein Binding; Protein Structure, Tertiary; Pyrroles; Receptors, Lysosphingolipid; Structure-Activity Relationship; Thioctic Acid | 2013 |
Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice.
Topics: Anabolic Agents; Animals; Female; Mice; Mice, Inbred C57BL; Osteoporosis; Ovariectomy; Pyrroles; Sphingosine-1-Phosphate Receptors | 2019 |